PAR logo

PAR

PAR Technology Corporation

$14.19
+$0.75(+5.58%)
41
Overall
60
Value
18
Tech
47
Quality
How is this score calculated?
Market Cap
$1.57B
Volume
585.79K
52W Range
$11.59 - $72.15
Target Price
$34.00

Latest News for PAR

Truist Financial Remains a Buy on Parker Hannifin (PH)
TipRanks Auto-Generated Intelligence Newsdesk8 hours agoMay 01, 2026

Truist Financial analyst Jamie Cook reiterated a Buy rating on Parker Hannifin today and set a price target of $1,147.00. According to TipRanks, Co......

Stifel Nicolaus Keeps Their Hold Rating on Parker Hannifin (PH)
TipRanks Auto-Generated Intelligence Newsdesk8 hours agoMay 01, 2026

In a report released today, Nathan Jones from Stifel Nicolaus maintained a Hold rating on Parker Hannifin, with a price target of $1,000.00. Jones ......

Barclays Sticks to Its Buy Rating for Parker Hannifin (PH)
TipRanks Auto-Generated Intelligence Newsdesk12 hours agoMay 01, 2026

In a report released today, Julian Mitchell from Barclays maintained a Buy rating on Parker Hannifin, with a price target of $1,020.00. According t......

Paradigm Biopharmaceuticals Launches $2m Share Purchase Plan After $14m Placement
TipRanks Australian Auto-Generated Newsdesk2 days agoApr 30, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals has completed a $14 million placement of 73,68......

Paradigm Hits 50% Dosing in Global Knee OA Trial and Bolsters Funding
TipRanks Australian Auto-Generated Newsdesk5 days agoApr 27, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an update. Paradigm Biopharmaceuticals reported continued momentum in its global Phase 3 tr......

Paradigm Biopharmaceuticals Launches Securities Purchase Plan With Options Package
TipRanks Australian Auto-Generated Newsdesk5 days agoApr 27, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has provided an update. Paradigm Biopharmaceuticals has announced a proposed securities purchase plan, un......

Paradigm Biopharmaceuticals Plans Major Share and Option Issue to Boost Capital
TipRanks Australian Auto-Generated Newsdesk5 days agoApr 27, 2026

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has outlined a proposed capital raising ......

Paradigm boosts funding to carry Phase 3 trial through key interim data
TipRanks Australian Auto-Generated Newsdesk5 days agoApr 27, 2026

An update from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has completed a significantly upsized A$14 m......

Analysts Offer Insights on Consumer Goods Companies: Inter Parfums (IPAR) and Universal Technical Institute (UTI)
Catie Powers9 days agoApr 22, 2026

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Inter Parfums (IPAR) and Universal Technical I......

PAR Technology Adds Voss Capital Board Observer in Agreement
TipRanks Auto-Generated Newsdesk16 days agoApr 15, 2026

The latest update is out from Par Technology ( ($PAR) ). On April 15, 2026, PAR Technology Corporation entered into a one-year Board Observer Agree......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 15 articles.

ABCD
1SymbolPriceChangeVol
2PAR$14.19+5.6%585.79K
3
4
5
6

Get PAR Technology Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.